Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS)
CNY 11.32
(-0.18%)
CNY 11.32
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.08 Billion | 3.97 Billion | 2.56 Billion | 3.02 Billion | 2.31 Billion | 1.82 Billion |
| Net Income | 1.44 Billion | 2.89 Billion | 2.61 Billion | 2.57 Billion | 1.85 Billion | 1.45 Billion |
| Depreciation & Amortization | 1.46 Billion | 837.7 Million | 620.45 Million | 546.9 Million | 522.52 Million | 514.64 Million |
| Deferred income taxes | -25.72 Million | 72.16 Million | -46.32 Million | -83.95 Million | -28.79 Million | -8.69 Million |
| Stock-based compensation | 90.41 Million | 57.07 Million | 34.52 Million | 36.29 Million | 21.4 Million | 6.02 Million |
| Change in working capital | -397.83 Million | -76.16 Million | -909.76 Million | -151.76 Million | -183.24 Million | -434.45 Million |
| Other non-cash items | 5.01 Billion | 192.83 Million | 251.35 Million | 99.05 Million | 130.54 Million | 285.74 Million |
| Investing Cash Flow | -1.02 Billion | -2.25 Billion | -1.96 Billion | -500.32 Million | 1.31 Billion | -2.9 Billion |
| Investments in PPE | -1.13 Billion | -1.14 Billion | -1.52 Billion | -830.4 Million | -703.19 Million | -655.01 Million |
| Acquisitions | 1.99 Million | 48.69 Million | 3.31 Million | 5.33 Million | 1.98 Million | 24.74 Million |
| Investment purchases | -704.65 Million | -416.18 Million | -786 Million | -157.13 Million | -159.82 Million | -350.08 Million |
| Sales/Maturities of investments | 834.86 Million | 415.35 Million | 270.04 Million | 383.88 Million | 235.68 Million | 140.48 Million |
| Other Investing Activities | -23.64 Million | -1.15 Billion | 69.9 Million | 97.99 Million | 1.93 Billion | -2.06 Billion |
| Financing Cash Flow | -1.93 Billion | 566.12 Million | -974.9 Million | -1.23 Billion | -2.06 Billion | 1.4 Billion |
| Debt repayment | -883.33 Million | -3.71 Billion | -2.59 Billion | -3.12 Billion | -3.49 Billion | -2.19 Billion |
| Dividends payments | -336.79 Million | -277.55 Million | -288.67 Million | -308.42 Million | -310.08 Million | -446.52 Million |
| Common Stock Repurchased | -821.53 Million | -780.55 Million | -938.08 Million | -503.69 Million | -25.2 Thousand | -5.42 Million |
| Common Stock Issuance | - | 780.55 Million | 938.08 Million | 503.69 Million | 25.2 Thousand | -2.47 Million |
| Other Financing Activities | -1.62 Billion | 4.67 Billion | 2 Billion | 2.25 Billion | 1.81 Billion | 4.04 Billion |
| Accounts receivables | 6.97 Billion | 2.38 Billion | -1.59 Billion | -647.41 Million | -177.17 Million | 319.86 Million |
| Accounts payables | -7.04 Billion | -1.92 Billion | 1.03 Billion | 963.79 Million | 196.67 Million | -574.47 Million |
| Inventory | -415.38 Million | -604.73 Million | -306.33 Million | -384.2 Million | -173.94 Million | -171.15 Million |
| Other working capital | 90.25 Million | 72.16 Million | -46.32 Million | -83.95 Million | -28.79 Million | -263.3 Million |
| Cash at beginning of period | 14.8 Billion | 11.69 Billion | 12.12 Billion | 10.94 Billion | 9.36 Billion | 8.96 Billion |
| Cash at end of period | 15.69 Billion | 14.17 Billion | 11.69 Billion | 12.12 Billion | 10.94 Billion | 9.36 Billion |
| Capital Expenditure | -1.13 Billion | -1.14 Billion | -1.52 Billion | -830.4 Million | -703.19 Million | -655.01 Million |
| Effect of forex changes on cash | 38.41 Million | 189.28 Million | -49.29 Million | -103.98 Million | 17.22 Million | 73.12 Million |
| Net cash flow / Change in cash | 883.4 Million | 2.48 Billion | -425.26 Million | 1.18 Billion | 1.58 Billion | 393.63 Million |
| Free Cash Flow | 2.95 Billion | 2.82 Billion | 1.04 Billion | 2.19 Billion | 1.6 Billion | 1.17 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 335.13 Million | 336.62 Million | 439.79 Million | 359.13 Million | 1.44 Billion | 268.21 Million |
| Depreciation & Amortization | - | 235.72 Million | 235.72 Million | 249.52 Million | 1.46 Billion | 249.52 Million |
| Deferred income taxes | - | - | - | -6.73 Billion | -25.72 Million | 598.02 Million |
| Stock-based compensation | - | 19.1 Million | - | 90.41 Million | 90.41 Million | -50.95 Million |
| Change in working capital | - | -779.47 Million | - | 6.64 Billion | -397.83 Million | -547.06 Million |
| Other non-cash items | 555.56 Million | 665.28 Million | 538.31 Million | 943.59 Million | 5.01 Billion | 684.9 Million |
| Investing Cash Flow | -702.28 Million | 255.09 Million | -584.07 Million | -282.41 Million | -1.02 Billion | -166.49 Million |
| Investments in PPE | -202.6 Million | -286.25 Million | -248.17 Million | -376.91 Million | -1.13 Billion | -211.8 Million |
| Acquisitions | 13.86 Million | 77.37 Million | 82.73 Million | 9.71 Million | 1.99 Million | 7.7 Million |
| Investment purchases | -491.98 Million | -361.11 Million | -307.54 Million | -265.51 Million | -704.65 Million | -9.94 Million |
| Sales/Maturities of investments | -15.66 Million | 714.92 Million | 5.83 Million | 444.51 Million | 834.86 Million | 59.45 Million |
| Other Investing Activities | 7.97 Million | 110.16 Million | -111.09 Million | -94.2 Million | -23.64 Million | -11.9 Million |
| Financing Cash Flow | -771.78 Million | -558.24 Million | -977.27 Million | 57.7 Million | -1.93 Billion | -1.08 Billion |
| Debt repayment | -355.49 Million | -100.64 Million | -817.06 Million | -128.51 Million | -883.33 Million | -1.15 Billion |
| Dividends payments | -204.87 Million | -201.76 Million | -33.45 Million | -336.79 Million | -336.79 Million | -336.79 Million |
| Common Stock Repurchased | - | -135.51 Million | - | -821.53 Million | -821.53 Million | 512.62 Million |
| Common Stock Issuance | - | - | - | - | - | -512.62 Million |
| Other Financing Activities | -922.4 Million | -457.6 Million | -160.21 Million | 1.12 Billion | -1.62 Billion | 286.02 Million |
| Accounts receivables | - | -817.37 Million | - | 6.97 Billion | 6.97 Billion | -814.11 Million |
| Accounts payables | - | - | - | - | -7.04 Billion | - |
| Inventory | - | 31.33 Million | - | -415.38 Million | -415.38 Million | 318.71 Million |
| Other working capital | - | 6.57 Million | - | 90.25 Million | 90.25 Million | -51.66 Million |
| Cash at beginning of period | 15.24 Billion | 15.11 Billion | 15.69 Billion | 14.41 Billion | 14.8 Billion | 14.1 Billion |
| Cash at end of period | 14.58 Billion | 15.25 Billion | 15.11 Billion | 15.69 Billion | 15.69 Billion | 14.04 Billion |
| Capital Expenditure | -202.6 Million | -286.25 Million | -248.17 Million | -376.91 Million | -1.13 Billion | -211.8 Million |
| Effect of forex changes on cash | -56.77 Million | 15.27 Million | 4.07 Million | -33.57 Million | 38.41 Million | -10.7 Million |
| Net cash flow / Change in cash | -654.54 Million | 140.68 Million | -573.69 Million | 1.28 Billion | 883.4 Million | -57.76 Million |
| Free Cash Flow | 688.08 Million | 479.93 Million | 729.94 Million | 1.17 Billion | 2.95 Billion | 990.83 Million |
VEII
WTFC
AMS
GISSAA
ICO
3388